
Danny Hong
Examiner (ID: 2374, Phone: (571)270-5107 , Office: P/3727 )
| Most Active Art Unit | 3727 |
| Art Unit(s) | 3723, 3727 |
| Total Applications | 485 |
| Issued Applications | 270 |
| Pending Applications | 0 |
| Abandoned Applications | 215 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13297753
[patent_doc_number] => 20180200413
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => DRUG-COATED MEDICAL DEVICES
[patent_app_type] => utility
[patent_app_number] => 15/742828
[patent_app_country] => US
[patent_app_date] => 2016-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11110
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15742828
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/742828 | DRUG-COATED MEDICAL DEVICES | Jul 7, 2016 | Abandoned |
Array
(
[id] => 12880354
[patent_doc_number] => 20180185293
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => Bacteria-Containing Oral Rapidly Disintegrating Tablet
[patent_app_type] => utility
[patent_app_number] => 15/740818
[patent_app_country] => US
[patent_app_date] => 2016-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6647
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15740818
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/740818 | Bacteria-Containing Oral Rapidly Disintegrating Tablet | Jul 4, 2016 | Abandoned |
Array
(
[id] => 11113506
[patent_doc_number] => 20160310479
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'METHYLPHENIDATE EXTENDED RELEASE CHEWABLE TABLET'
[patent_app_type] => utility
[patent_app_number] => 15/200625
[patent_app_country] => US
[patent_app_date] => 2016-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16304
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15200625
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/200625 | Methylphenidate extended release chewable tablet | Jun 30, 2016 | Issued |
Array
(
[id] => 12880930
[patent_doc_number] => 20180185485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => Polymeric Nanoparticles for Enhancing HIFU-Induced Ablation
[patent_app_type] => utility
[patent_app_number] => 15/740194
[patent_app_country] => US
[patent_app_date] => 2016-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5260
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15740194
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/740194 | Polymeric Nanoparticles for Enhancing HIFU-Induced Ablation | Jun 30, 2016 | Abandoned |
Array
(
[id] => 13311115
[patent_doc_number] => 20180207094
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-26
[patent_title] => IMPROVED TOPICAL KETOPROFEN FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 15/742708
[patent_app_country] => US
[patent_app_date] => 2016-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5048
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15742708
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/742708 | IMPROVED TOPICAL KETOPROFEN FORMULATIONS | Jun 29, 2016 | Abandoned |
Array
(
[id] => 16755240
[patent_doc_number] => 10973766
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-13
[patent_title] => Oral pharmaceutical dosage form for the delivery of a peptide and/or protein
[patent_app_type] => utility
[patent_app_number] => 15/739809
[patent_app_country] => US
[patent_app_date] => 2016-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 31
[patent_no_of_words] => 18045
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 197
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15739809
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/739809 | Oral pharmaceutical dosage form for the delivery of a peptide and/or protein | Jun 26, 2016 | Issued |
Array
(
[id] => 16154009
[patent_doc_number] => 20200215237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-09
[patent_title] => ABSORBABLE IRON-BASED ALLOY IMPLANTABLE MEDICAL DEVICE
[patent_app_type] => utility
[patent_app_number] => 16/063798
[patent_app_country] => US
[patent_app_date] => 2016-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8911
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16063798
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/063798 | Absorbable iron-based alloy implantable medical device | Jun 26, 2016 | Issued |
Array
(
[id] => 13090985
[patent_doc_number] => 10064816
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-04
[patent_title] => Treatment of sexual dysfunction
[patent_app_type] => utility
[patent_app_number] => 15/303578
[patent_app_country] => US
[patent_app_date] => 2016-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15341
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15303578
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/303578 | Treatment of sexual dysfunction | Jun 9, 2016 | Issued |
Array
(
[id] => 11323884
[patent_doc_number] => 20160354495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-08
[patent_title] => 'Multicore Magnetic Particles'
[patent_app_type] => utility
[patent_app_number] => 15/171383
[patent_app_country] => US
[patent_app_date] => 2016-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3864
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15171383
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/171383 | Multicore Magnetic Particles | Jun 1, 2016 | Abandoned |
Array
(
[id] => 18909361
[patent_doc_number] => 11872324
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-16
[patent_title] => Materials and methods for tissue regeneration
[patent_app_type] => utility
[patent_app_number] => 15/576718
[patent_app_country] => US
[patent_app_date] => 2016-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 24
[patent_no_of_words] => 34101
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 115
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15576718
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/576718 | Materials and methods for tissue regeneration | May 25, 2016 | Issued |
Array
(
[id] => 11066165
[patent_doc_number] => 20160263129
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'Controlled Release Doxycycline'
[patent_app_type] => utility
[patent_app_number] => 15/161812
[patent_app_country] => US
[patent_app_date] => 2016-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11675
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15161812
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/161812 | Controlled Release Doxycycline | May 22, 2016 | Abandoned |
Array
(
[id] => 12858175
[patent_doc_number] => 20180177899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => HYDROPHILIC PARTICLES, METHOD FOR PRODUCING THE SAME, AND CONTRAST AGENT UTILIZING SAME
[patent_app_type] => utility
[patent_app_number] => 15/580977
[patent_app_country] => US
[patent_app_date] => 2016-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6387
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15580977
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/580977 | HYDROPHILIC PARTICLES, METHOD FOR PRODUCING THE SAME, AND CONTRAST AGENT UTILIZING SAME | May 18, 2016 | Abandoned |
Array
(
[id] => 11127913
[patent_doc_number] => 20160324888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-10
[patent_title] => 'METHOD FOR TREATING INTERVERTEBRAL DISC DEGENERATION'
[patent_app_type] => utility
[patent_app_number] => 15/148488
[patent_app_country] => US
[patent_app_date] => 2016-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3857
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15148488
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/148488 | Method for treating intervertebral disc degeneration | May 5, 2016 | Issued |
Array
(
[id] => 16041021
[patent_doc_number] => 10682361
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-16
[patent_title] => Sustained release bimatoprost, bimatoprost analogs, prostamides and prostaglandins for fat reduction
[patent_app_type] => utility
[patent_app_number] => 15/134792
[patent_app_country] => US
[patent_app_date] => 2016-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 16
[patent_no_of_words] => 2754
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15134792
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/134792 | Sustained release bimatoprost, bimatoprost analogs, prostamides and prostaglandins for fat reduction | Apr 20, 2016 | Issued |
Array
(
[id] => 11611548
[patent_doc_number] => 09649391
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-16
[patent_title] => 'Particles with multiple functionalized surface domains'
[patent_app_type] => utility
[patent_app_number] => 15/097676
[patent_app_country] => US
[patent_app_date] => 2016-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 39
[patent_no_of_words] => 23491
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 163
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15097676
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/097676 | Particles with multiple functionalized surface domains | Apr 12, 2016 | Issued |
Array
(
[id] => 12702544
[patent_doc_number] => 20180126014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-10
[patent_title] => COMPOSITIONS FOR ENHANCING DELIVERY OF AGENTS ACROSS THE BLOOD BRAIN BARRIER AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/566046
[patent_app_country] => US
[patent_app_date] => 2016-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32456
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15566046
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/566046 | COMPOSITIONS FOR ENHANCING DELIVERY OF AGENTS ACROSS THE BLOOD BRAIN BARRIER AND METHODS OF USE THEREOF | Apr 11, 2016 | Abandoned |
Array
(
[id] => 11023535
[patent_doc_number] => 20160220491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'Method of Preparing Biologically Formulations Active'
[patent_app_type] => utility
[patent_app_number] => 15/092948
[patent_app_country] => US
[patent_app_date] => 2016-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 11818
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15092948
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/092948 | Method of preparing biologically formulations active | Apr 6, 2016 | Issued |
Array
(
[id] => 11023561
[patent_doc_number] => 20160220516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-04
[patent_title] => 'Aqueous Pharmaceutical Formulation of Tapentadol for Oral Administration'
[patent_app_type] => utility
[patent_app_number] => 15/093522
[patent_app_country] => US
[patent_app_date] => 2016-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13293
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15093522
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/093522 | Aqueous Pharmaceutical Formulation of Tapentadol for Oral Administration | Apr 6, 2016 | Abandoned |
Array
(
[id] => 14881675
[patent_doc_number] => 10420858
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-24
[patent_title] => Cell carrier for skin tissue regeneration containing chitooligosaccharide and method for producing the same
[patent_app_type] => utility
[patent_app_number] => 15/754508
[patent_app_country] => US
[patent_app_date] => 2016-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 4741
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 195
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15754508
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/754508 | Cell carrier for skin tissue regeneration containing chitooligosaccharide and method for producing the same | Apr 5, 2016 | Issued |
Array
(
[id] => 12323604
[patent_doc_number] => 09943846
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-04-17
[patent_title] => Limit size lipid nanoparticles and related methods
[patent_app_type] => utility
[patent_app_number] => 15/087721
[patent_app_country] => US
[patent_app_date] => 2016-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 25
[patent_no_of_words] => 10813
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15087721
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/087721 | Limit size lipid nanoparticles and related methods | Mar 30, 2016 | Issued |